Refinement and Assessment of New Magnetic Resonance Imaging Technologies for Neurological Exams
Launched by UNIVERSITY OF MICHIGAN · Aug 20, 2008
Trial Information
Current as of April 24, 2025
Completed
Keywords
ClinConnect Summary
This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the brain, spine, and head \& neck regions.
Software and hardware are constantly being improved, new machines replace old machines, software is updated and improved as are the devices used to produce better MRI images.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • If you are a male or a non-pregnant female patient
- • Normal volunteer
- • presenting to MRI for a clinically-ordered neurological or head and neck MRI exam
- Exclusion Criteria:
- • Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator.
- • Pregnant patients or patients who are lactating.
- • A patient who is claustrophobic
Trial Officials
Ashok Srivinasan, MD
Principal Investigator
University of Michigan
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
